In 1989 was created Integra LifeSciences, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Plainsboro. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Integra LifeSciences, startups are often financed by Yissum Technology Transfer Company of the Hebrew University, Clal Biotechnology Industries, Technion Research & Development Foundation. The meaningful sponsors for the fund in investment in the same round are Yissum Technology Transfer Company of the Hebrew University. In the next rounds fund is usually obtained by Yissum Technology Transfer Company of the Hebrew University.
This organization was formed by Richard E. Caruso.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2014. The fund is generally included in less than 2 deals every year.
The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Avraham Pharmaceuticals, Avraham Pharmaceuticals. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Related Funds
Fund Name | Location |
Alclan | - |
Anzu Partners | District of Columbia, United States, Washington |
Beijing Hualian Group | Beijing, Beijing, China |
Carlin Investments | California, Encino, United States |
CCBI Tech Venture | China, Jiangsu, Suzhou |
Compugen | Israel, Tel Aviv, Tel Aviv District |
Coronis Medical Ventures | California, Sunnyvale, United States |
Lakeland Equity Partners | - |
Meritage Group LP | California, San Francisco, United States |
Nabo Capital | - |
Pi Campus | Italy, Lazio, Rome |
Qipan Investment | China, Shanghai |
Richard M. Fairbanks Foundation | Indiana, Indianapolis, United States |
SHASHIN KAGAKU | Japan, Kyoto, Kyoto Prefecture |
Shengyun Guanli Zixun | China, Jinan, Shandong |
Tel Aviv Angel Group | Israel, Tel Aviv, Tel Aviv District |
Tower Gate Capital | Mayfair, United Kingdom, Westminster |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.